Sepsis is deadly on its own — but in diabetes, the baseline oxidative stress turns it into a full-blown organ-killing fire. In this Deep Dive, Dr. Mike and Don unpack a new study where water-soluble, hydroxylated fullerene C60 acts like a nanoscale “electron sink,” neutralizing free radicals the way depleted antioxidant enzymes can’t. In a diabetic sepsis model (CLP), C60 sharply reduced lipid peroxidation and protected multiple organ systems — liver, heart, and brain — while also boosting native antioxidant capacity (catalase). The big question: is this just an acute rescue tool… or a future prophylactic “organ armor” strategy?

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Effects of fullerenol C60 on the liver, heart and brain tissues of streptozotocin‑induced diabetic rats with sepsis

-

Key Quotes From Dr. Mike:

"Think of sepsis as a massive fire breaking out in a house… and diabetes like having gasoline already spilled all over the floor."

Regarding C60: “It has this amazing capacity to attract and neutralize rogue, unbalanced electrons from free radicals.”

“In the liver, there was vastly reduced hepatocyte necrosis.”

“In the heart, they saw reduced interstitial fibrosis and way less myocardial disorganization.”

“They noted a major decrease in inflammatory cellularity in the brain.”

“It’s (C60) not just blocking the fire—it’s like upgrading the body’s sprinkler system.”

-

Key Points

-

Episode timeline

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight:

Website

Instagram

YouTube

Facebook

Mitochondria aren’t just your cell’s power plants — they may also contain a built-in kill switch. In this Deep Dive, Dr. Mike unpacks a 2026 Annual Review of Biophysics paper arguing that ATP synthase (the same machine that makes your ATP) can morph into the mitochondrial permeability transition pore (PT pore) under severe stress — especially calcium overload. You’ll learn the “death finger” model (subunit-e pulling a lipid plug), why cyclophilin D and inorganic phosphate help trigger the switch, and why this matters for real-world tissue injury like stroke and heart attack reperfusion damage. Then comes the twist: brine shrimp (sea monkeys) appear to lack this lethal pore — thanks to a tiny structural tweak that may hint at future strategies to “relax the tension” and keep our cellular dams from blowing.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

The Mitochondrial Permeability Transition Pore: Past, Present, and Future

-

Key Quotes From Dr. Mike:

“For decades, the exact molecular identity of the self-destruct mechanism was a huge mystery in biophysics.”

“Your mitochondria actually have exactly that — a built-in kill switch.”

“When your mitochondria get overwhelmed by too much calcium, they can open up the permeability transition pore.”

“You can picture it as a literal finger hooking into a fatty lipid plug... When there’s a massive overload of calcium, that structural finger just pulls the plug.”

“We are basically carrying around a vital energy machine that moonlights as an executioner.”

-

Key Points

-

Episode timeline

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight:

Website

Instagram

YouTube

Facebook

Emergency medicine is built on brute force — shock the heart, slam vasopressors, crank the numbers. But septic shock exposes the flaw in that instinct: the harder you squeeze vessels from the outside, the more you can starve the microcirculation that actually feeds the kidneys, liver, and lungs. In this Deep Dive, we unpack a 2026 Biomedicine & Pharmacotherapy study testing methylene blue as a precision countermeasure for vasoplegic septic shock. The core mechanism: cytokine-driven iNOS overexpression floods nitric oxide, overactivating the NO → sGC → cGMPrelaxation cascade and collapsing vascular tone. Instead of “chemical duct tape” (high-dose catecholamines), methylene blue blocks the pathway at the source—oxidizing sGC’s heme iron to prevent NO binding and inhibiting further NO production—while also acting as a redox-active electron carrier under oxidative stress. In a CLP sepsis model, 10 mg/kg produced the “Goldilocks” effect: improved MAP, protected lungs and kidneys, reduced IL-1β, boosted antioxidant defenses (SOD, GSH), and lowered lipid peroxidation (MDA). But at 100 mg/kg, the pharmacology flipped—pro-oxidant stress, catastrophic liver injury, and early death. The episode closes with the translational bridge: rat-to-human scaling places the effective dose around ~1.6 mg/kg, aligning with real ICU protocols, while highlighting key limitations (12-hour window, lactate lag, female-only cohort and estrogen effects).

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Dose-dependent effects of methylene blue on hemodynamics, cytokines, oxidative stress, and organ dysfunction in a rat model of CLP-induced sepsis: An experimental study

-

Key Quotes From Dr. Mike:

“In emergency medicine, the instinct is always to overpower the crisis with brute force.”

Regarding vasoplegia: "The engine driving it is an overproduction of nitric oxide.”

“Methylene blue… oxidizes the heme iron… preventing nitric oxide from binding to sGC.”

“It (methylene blue) restores normal vascular tone without aggressively squeezing the vessel from the outside.”

“At super-therapeutic concentrations, methylene blue stops acting as an efficient electron carrier... Instead of smoothly passing electrons… it begins indiscriminately stealing electrons and auto-oxidizing.”

“That is the inherent danger of redox-active compounds.”

-

Key Points

-

Episode timeline

-

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight:

Website

Instagram

YouTube

Facebook

What if the spinach in your salad, the berries in your smoothie, and the caffeine in your coffee aren’t “fuel” at all — but evolved plant defense chemicals that can directly modify your mitochondria? In this deep dive, we unpack a 2025 paper from the International Journal of Molecular Sciences (“Plant Secondary Metabolites as Modulators of Mitochondrial Health”) and follow the mechanisms step-by-step: how mitochondria maintain themselves through biogenesis, fusion/fission, and mitophagy; how compounds like berberine can trigger a controlled “fake energy crisis” to induce cleanup + rebuilding; how caffeine can interrupt apoptosis signaling under UV stress; why astaxanthin can reducemitophagy during acute oxidative panic to prevent cellular self-cannibalism; and why some “plant” benefits (like urolithin A) depend entirely on your gut microbiome. Finally, we hit the paradox: these same metabolites can become selectively cytotoxic to cancer cells—or become dangerous when isolated into high-dose supplements, with real toxicity and drug-interaction risk. The takeaway: food isn’t just calories — it’s environmental code.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Plant Secondary Metabolites as Modulators of Mitochondrial Health: An Overview of Their Anti-Oxidant, Anti-Apoptotic, and Mitophagic Mechanisms

-

Key Quotes From Dr. Mike:

“The spinach in your salad… the berries in your smoothie… and even the caffeine in your morning coffee were actually highly evolved chemical weapons.”

“We really have to stop thinking of plants just as vitamins and start looking at them as complex chemical defense systems.”

“Berberine… creates a fake crisis to force an upgrade.”

“Caffeine… effectively jams the self-destruct button.”

“Think of the plant compounds you consume as environmental software updates.”

-

Key Points

-

Episode timeline

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight:

Website

Instagram

YouTube

Facebook

Photobiomodulation therapy (PBMT) is marketed like universal biology: shine the right wavelength, hit cytochrome c oxidase, boost ATP, accelerate healing. But this Deep Dive unpacks a hidden variable that can make “standard dosing” either ineffective or unsafe: melanin. Using a 2026 narrative review from researchers at the University of São Paulo, we trace the physics of a photon entering the body, how melanin’s absorption overlaps the therapeutic “optical window,” and why simply “turning up the laser” can backfire — creating heat and reactive species in the epidermis while deeper target tissues get little benefit. We also confront a data problem: trials may include darker phototypes, but too often outcomes aren’t analyzed by skin type, creating a misleading “average” that masks risk. Finally, we outline practical fixes — wavelength selection, spot size adjustments, and pigmentation-sensitive, feedback-guided dosimetry — so PBMT can become truly personalized and equitable.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Is photobiomodulation therapy free from racial bias?: a narrative review of skin pigmentation

-

Key Quotes From Dr. Mike:

Regarding melanin: “It literally absorbs the photons before they can ever reach the deeper tissues.”

“For individuals with darker skin tones, this can result in totally subtherapeutic treatments.”

“They currently do not differentiate dosing parameters based on skin pigmentation.”

“The physics of a photon is constant. But the biological filter it’s passing through is wildly diverse.”

“At 660 nm… 21 mm in lighter skin… but in darker skin it drops to 14 mm.”

“We need to stop treating light therapy like a one-size-fits-all t-shirt… and treat it like a custom tailored suit.”

-

Key Points

-

Episode timeline

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight:

Website

Instagram

YouTube

Facebook

Upon Don Bailey's return to the Deep Dive episodes, he and Dr. Mike reframe fatigue, aging, and neurodegeneration through one core process: mitophagy — the cell’s highly selective mitochondrial recycling program. The episode starts with a hard truth: “engineering-style” diagnoses feel comforting, but chronic fatigue and cognitive decline live in a murky zone standard tests rarely capture. From there, the conversation builds a vivid model of mitochondrial energy production (OXPHOS), the unavoidable “exhaust” of ROS, and the multi-tiered quality control stack that keeps your cellular power grid from collapsing: biogenesis (PGC-1α), dynamics (fusion/fission), and mitophagy (the scrapyard).

Then it goes deeper — showing how mitophagy failure can turn mitochondrial damage into neuroinflammation (via leaked bacterial-like mtDNA and the NLRP3 inflammasome) and even “cellular rust” (ferroptosis) when iron-driven lipid peroxidation spirals out of control. The episode also tackles the paradox: mitophagy is protective — until extreme stress pushes it into overdrive, potentially tipping into ferroptosis. Finally, it translates the research into real levers: exercise as hormetic signaling (MICT vs HIIT), the AMPK↔mTOR seesaw, and biohacking tools like urolithin A, spermidine, resveratrol, and adaptogens — not as exercise replacements, but as precision amplifiers that help you stay in the “Goldilocks zone.”

(Educational content only, not medical advice.)

-

References From Episode:

Mechanistic Modulation of Autophagy by Bioactive Natural Products: Implications for Human Aging and Longevity

Early mitophagy activation by Urolithin A prevents, but late activation does not reverse, age-related cognitive impairment

Mitophagy as a therapeutic target for exercise-induced fatigue: modulation by natural compounds and mechanistic insights

Mitophagy in Alzheimer’s disease and its potential as a therapeutic target

-

Key Quotes From Episode:

“Mitophagy is the scrapyard.”

“If the trash isn’t being collected, your cells become crowded with clunker mitochondria.”

“We are fundamentally as young as our mitochondrial recycling program.”

Regarding Urolithin A: “The supplement isn’t a replacement for the gym. It’s an amplifier.”

“You cannot supplement your way out of a sedentary lifestyle.”

-

Key Points

-

Episode timeline

00:00–03:30 — Why “engineering-style” diagnoses fail for fatigue/aging/brain fog

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight:

Website

Instagram

YouTube

Facebook

In this Energy Code Deep Dive episode, Dr. Mike breaks down a modern (and slightly unsettling) obesity paper: blue light exposure worsened obesity in high-fat diet–fed mice — not just through “sleep/circadian disruption” in the abstract, but via signals consistent with mitochondrial dysfunction and oxidative stress in subcutaneous white fat. The study compares normal vs high-fat diet mice under white light vs blue light and finds that blue light, in the high-fat context, is associated with more weight/fat gain, worse glucose handling, lower whole-body energy expenditure, and a strong tissue-specific signal in inguinal white adipose tissue (iWAT) — a depot closer to the surface that may be more vulnerable to light penetration. Mechanistically, the paper points toward suppressed oxidative phosphorylation gene expression plus higher ROS/lipid peroxidation and weaker antioxidant defenses in iWAT. The key takeaway: in a high-fat environment, blue light may act like a metabolic amplifier — increasing load while weakening the machinery that should burn fuel cleanly.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Blue light exposure exacerbates obesity in high-fat diet-fed mice by inducing mitochondrial dysfunction in the white adipose tissue

-

Key Quotes From Dr. Mike:

“Blue light, obesity, fat tissue, and mitochondrial dysfunction… modern and a little unsettling.”

“Could the kind of light we are increasingly surrounded by actually make metabolic dysfunction worse… by directly damaging the way fat tissue handles energy?”

“In mice eating a high-fat diet, blue light exposure led to more weight gain and more body fat than white light exposure.”

“Blue light exposed high-fat mice had lower oxygen consumption, lower carbon dioxide production, and lower heat production.”

“Light is not just visual information, it is metabolic information.”

-

Key Points

-

Episode timeline

0:19–0:47 — Intro + why this paper is “modern and unsettling”

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight:

Website

Instagram

YouTube

Facebook

In this Energy Code Deep Dive episode, Dr. Mike unpacks a paper that reframes ALS at a deeper level: ALS may begin as an energy regulation failure, starting in the hypothalamus, before it becomes an obvious motor neuron story.The hypothalamus isn’t just “another brain region”; it’s the body’s metabolic control room — governing hunger, energy expenditure, hormones, and fuel signaling. The paper shows that in ALS mouse models, the hypothalamus develops early mitochondrial bioenergetic impairment (including reduced spare respiratory capacity) alongside neuroimmune activation (astrocytes and microglia) and melanocortin circuit disruption (POMC/AgRP imbalance) that could help explain early hypermetabolism and weight loss seen in ALS. Most provocatively, early metabolic modulation (TMZ) restored hypothalamic bioenergetics, reduced glial activation, normalized aspects of circuit signaling, delayed onset, and extended survival — suggesting the “first domino” may be a failing energy command center, not just downstream motor collapse.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

The hypothalamus is an early site of mitochondrial failure and neuro-immune circuit disruption in amyotrophic lateral sclerosis

-

Key Quotes From Dr. Mike:

“ALS may not begin only as a motor neuron story. It may also begin as an energy regulation story.”

“Mitochondrial dysfunction shows up in the hypothalamus before symptoms begin.”

“If that is true, then ALS is not just a disease of movement. It is also a disease of failed energy coordination.”

“These hypothalamic mitochondrial changes… happened before major motor symptoms.”

“…if you intervene early at the level of hypothalamic energy failure, you may be able to change the trajectory of disease.”

-

Key Points

-

Episode timeline

0:19–0:34 — Intro + why this paper could change how we think about ALS

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight:

Website

Instagram

YouTube

Facebook

In this Energy Code Deep Dive episode, Dr. Mike breaks down a provocative neuroprotection review: low-dose methylene blue and near-infrared (NIR) light may look like totally different therapies — one is a molecule, one is photons — but the paper argues they converge on the same core target: mitochondrial respiration. You’ll hear a simple “neurons as cities / mitochondria as power plants” model for neurodegeneration, why methylene blue can function like an alternate electron shuttle in the electron transport chain, how NIR light can energize cytochrome oxidase, and why both approaches may widen the neuron’s “energy margin” during stress. The takeaway isn’t “magic cures.” It’s a disciplined mitochondrial lens: improving the power supply may give repair, plasticity, and survival systems the bandwidth to work.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

Protection against neurodegeneration with low-dose methylene blue and near-infrared light

-

Key Quotes From Dr. Mike:

“Two very different therapies (methylene blue & NIR light) may be helping the brain in basically the same way.”

“Methylene blue, at low doses, appears to help by acting like an alternate electron shuttle.”

“This paper makes the point that methylene blue has a hormetic dose response…”

“…near infrared light is more like directly energizing one of the key turbines in the mitochondrial power plant.”

“Different tools, same target, and that target is mitochondrial respiration.”

“…if you can stabilize mitochondrial respiration, you may be able to widen that energy margin and make neurons harder to kill.”

-

Key Points

-

Episode timeline

0:19–0:34 — Show open + why this paper matters

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight:

Website

Instagram

YouTube

Facebook

In this Energy Code Deep Dive episode, Dr. Mike breaks down a practical 8-week human study on shilajit and performance where it actually matters: after fatigue sets in. Recreationally active young men took placebo, 250 mg/day, or 500 mg/day, then got pushed through a brutal leg-extension fatigue protocol to see how much strength they lost — not just how strong they were fresh. The standout finding: in the stronger half of subjects, the 500 mg group preserved significantly more maximal isometric strength post-fatigue — and showed a quieter signal on serum hydroxyproline, a marker often used to reflect collagen/connective-tissue turnover. Bottom line: this paper doesn’t claim “instant strength.” It suggests shilajit may be more interesting as a fatigue-resistance + tissue-support tool — at the right dose, in the right population.

(Educational content only, not medical advice.)

-

Article Discussed in Episode:

The effects of Shilajit supplementation on fatigue-induced decreases in muscular strength and serum hydroxyproline levels

-

Key Quotes From Dr. Mike:

“In that stronger subgroup, the high dose shilait group lost significantly less maximal isometric strength after the fatiguing protocol…”

“So in simple terms, the men taking 500 mg per day of Sheelajit held on to their strength better once fatigue hit.”

“This was not a study showing Shilait magically blocks exercise damage… It is more a study suggesting that over time, the higher dose may support the tissue environment…”

“The strongest and cleanest finding is this… 500 mg per day… helped preserve maximal strength better after fatigue…”

“Sometimes performance support is not about creating more force at the start. Sometimes it is about losing less force when fatigue tries to take it away.”

-

Key Points

The study asks a real-world question: how much strength do you lose when you’re tired?

Design: recreationally active young men; placebo vs 250 mg/day vs 500 mg/day for 8 weeks.

Test: maximal isometric strength pre-fatigue, then 2×50 maximal concentric isokinetic leg extensions, then post-fatigue testing.

Primary performance signal showed up in the upper 50% (stronger subjects): 500 mg/day = less post-fatigue strength loss.

The lower dose (250 mg/day) did not clearly separate from placebo in that stronger subgroup.

Hydroxyproline (HYP) was used as an indirect marker of collagen/connective-tissue breakdown.

In the stronger subgroup, the 500 mg/day group had lower baseline HYP vs low dose and placebo after supplementation.

No big claims of “massive strength gain,” “weight change,” or “muscle growth.” The story is fatigue-retention, not “overnight PRs.”

Mechanistic framing is suggestive (ATP/mitochondrial support is discussed), but the study itself is performance + serum marker, not deep mitochondrial assays.

Limitations: young men only, specific fatigue model (concentric-dominant), and funding/source considerations.

-

Episode timeline

0:19–0:34 — Show open + setup for a shilajit performance Deep Dive

0:34–1:30 — The question: 8 weeks of shilajit—does it help strength retention under fatigue + connective tissue signals?

1:38–2:14 — What shilajit is (Ayurvedic mineral-rich exudate; fulvic acids, DBPs, minerals)

2:14–2:58 — Study design: placebo vs 250 mg/day vs 500 mg/day; 8-week supplementation

2:40–3:22 — The fatigue protocol + why “strength loss under fatigue” is the real-world metric

3:27–4:14 — Hydroxyproline explained as a collagen/connective-tissue breakdown signal

4:15–5:01 — Main finding: overall modest, but stronger subgroup shows a clearer effect

4:29–5:36 — Headline: 500 mg/day group lost less maximal isometric strength post-fatigue (in stronger half)

5:36–6:09 — Dose specificity: 250 mg/day didn’t separate clearly; possible threshold effect at 500 mg

6:13–7:38 — Hydroxyproline results + why the concentric-only protocol matters for interpretation

7:59–9:04 — Mechanistic framing (ATP/mitochondria discussion as a plausible lens)

9:04–10:31 — What the study did not show + disciplined interpretation

10:35–11:15 — Limitations + conflict-of-interest note

11:19–13:49 — Synthesis: shilajit as “hold the line under fatigue” support + wrap

Dr. Mike's #1 recommendations:

Deuterium depleted water: Litewater (code: DRMIKE)

-

Stay up-to-date on social media:

Dr. Mike Belkowski:

Instagram

LinkedIn

BioLight:

Website

Instagram

YouTube

Facebook